Form 4 Filing for Scholl Hendrik Peter

Hendrik Peter Scholl, Chief Medical Officer of BELITE BIO, INC, reported the sale of American depositary shares on October 1, 2026. The sales were executed under a Rule 10b5-1 trading plan. A total of 480 shares were sold in multiple transactions at prices ranging from $163.6 to $170.02. The weighted average prices for different tranches of sales were reported, with the lowest weighted average price being $163.6 for 200 shares and the highest weighted average price being $170.02 for 2 shares. Following these transactions, the post-transaction shares owned by the reporting person are 14,500. The filing indicates indirect ownership through Bioptima Ltd.